Chemical Structure : KY0418
货号: PC-28747Not For Human Use, Lab Use Only.
KY0418 is a specific covalent and orally bioavailable inhibitor of glutathione peroxidase 4 (GPX4) with inhibitory constant (Ki) of 0.3 uM, specifically targets GPX4SeCys46 to induce ferroptosis.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
KY0418 is a specific covalent and orally bioavailable inhibitor of glutathione peroxidase 4 (GPX4) with inhibitory constant (Ki) of 0.3 uM, specifically targets GPX4SeCys46 to induce ferroptosis.
KY0418 strongly suppressed the activity of purified GPX4-mediated reduction of tert-butyl hydroperoxide (TBHP) or cumene hydroperoxide in vitro.
KY0418 targets GPX4SeCys46 with superior selectivity over established covalent inhibitors.
KY0418 demonstrates near-nanomolar potency in most CCLs, fully rescued by Lip-1 and deferoxamine (DFO).
KY0418 shows strong cytotoxicity in mouse cancer cells, including MC-38 from the colorectum, 4T1 from breast, a T cell lymphoma EL4 line, and Lewis lung carcinoma (LLC1) cells in 2-D and 3-D cultures.
KY0418 also triggers GPX4 destabilization and degradation in CCLs, ensuring irreversible GPX4 blockade.
KY0418 acutely induces hallmarks of ferroptosis in ML210-pv-ALI model.
KY0418 remodels tissue metabolism in vivo via GPX4 inhibition, and a hydroxyl radical probe reports ferroptosis ex vivo.
KY0418 suppresses bulk tumor growth variably and kills CTCs in MC-38 subcutaneous allografts mouse models.
| 分子量 | 588.62 | |
| 分子式 | C28H35F3N8O3 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Naowarojna N, et al. Cell. 2026 Oct 21:S0092-8674(26)01200-6.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright